Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/26818
Title: A Synthetic DNA Construct to Evaluate the Recovery Efficiency of Cell-Free DNA Extraction and Bisulfite Modification.
Austin Authors: Goh, Su Kah ;Cox, Daniel R A ;Wong, Boris Ka Leong;Musafer, Ashan;Witkowski, Tom ;Do, Hongdo;Muralidharan, Vijayaragavan ;Dobrovic, Alexander 
Affiliation: Pathology Department, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
School of Cancer Medicine, La Trobe University, Bundoora, Victoria, Australia
The University of Melbourne, Parkville Precinct, Victoria, Australia
Olivia Newton-John Cancer Research Institute
Surgery (University of Melbourne)
Hepatopancreatobiliary Surgery
Victorian Liver Transplant Unit
Issue Date: 21-Jun-2021
Date: 2021-06-21
Publication information: Clinical Chemistry 2021; 67(9): 1201-1209
Abstract: Despite improvements in the genetic and epigenetic analysis of cell-free DNA (cfDNA), there has been limited focus on assessing the preanalytical variables of recovery efficiency following cfDNA extraction and bisulfite modification. Quantification of recovery efficiency after these steps can facilitate quality assurance and improve reliability when comparing serial samples. We developed an exogenous DNA Construct to Evaluate the Recovery Efficiency of cfDNA extraction and BISulfite modification (CEREBIS) after cfDNA extraction and/or subsequent bisulfite modification from plasma. The strategic placement of cytosine bases in the 180 bp CEREBIS enabled PCR amplification of the construct by a single primer set both after plasma DNA extraction and following subsequent bisulfite modification. Plasma samples derived from 8 organ transplant donors and 6 serial plasma samples derived from a liver transplant recipient were spiked with a known number of copies of CEREBIS. Recovery of CEREBIS after cfDNA extraction and bisulfite modification was quantified with high analytical accuracy by droplet digital PCR. The use of CEREBIS and quantification of its recovery was useful in identifying problematic extractions. Furthermore, its use was shown to be invaluable towards improving the reliability of the analysis of serial samples. CEREBIS can be used as a spike-in control to address the preanalytical variable of recovery efficiency both after cfDNA extraction from plasma and following bisulfite modification. Our approach can be readily implemented and its application may have significant benefits, especially in settings where longitudinal quantification of cfDNA for disease monitoring is necessary.
URI: https://ahro.austin.org.au/austinjspui/handle/1/26818
DOI: 10.1093/clinchem/hvab095
Journal: Clinical Chemistry
PubMed URL: 34151944
Type: Journal Article
Subjects: DNA extraction
DNA methylation
bisulfite modification
cell-free DNA
ddPCR
liquid biopsy
preanalytical
recovery efficiency
Appears in Collections:Journal articles

Show full item record

Page view(s)

74
checked on Dec 25, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.